NCD Japan Forum 2011
date : 11/29/2011
>>★Short video on the day (4 min, YouTube)
On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
Exhibition date:2011-11-29
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-02
[Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)









